Lepirudin

Lepirudin

Systematic (IUPAC) name
[Leu1,Thr2]-63-desulfohirudin
Clinical data
Trade names	Refludan
AHFS/Drugs.com	monograph
Pregnancy category	US: B (No risk in non-human studies)
Legal status	Prescription (US)
Routes of administration	SQ or IV
Pharmacokinetic data
Bioavailability	100
Biological half-life	~1.3 hours
Excretion	Renal
Identifiers
CAS Number	120993-53-5 Y
ATC code	B01AE02 (WHO)
IUPHAR/BPS	6469
DrugBank	DB00001 N
UNII	Y43GF64R34 N
KEGG	D03692 Y
ChEMBL	CHEMBL1201666 N
Chemical data
Formula	C288H448N80O110S6
Molecular mass	6983.5 g/mol
NY (what is this?)  (verify)

Lepirudin is an anticoagulant that functions as a direct thrombin inhibitor.

Brand name: Refludan, Generic: Lepirudin rDNA for injection.

Lepirudin is a recombinant hirudin derived from yeast cells. It is almost identical to hirudin extracted from Hirudo medicinalis. It differs by the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63.

Lepirudin may be used as an anticoagulant when heparins (unfractionated or low-molecular-weight) are contraindicated because of heparin-induced thrombocytopenia.

Market withdrawal

Bayer announced that it ceased the production of lepirudin (Refludan) on May 31, 2012. At the time of the announcement, the company expected that supply from wholesalers was going to be depleted by mid-2013.

External links

• DDB 30082